A recent report suggests that a SS18-SSX fusion protein containing SWI/SNF complex in synovial sarcoma cell lines leads to displacement of PRC2/EZH2 at SOX2 loci, resulting in loss of the repressive H3K27Me3 marks and increased SOX2 expression [9]. Here, EZH2 is linked to synovial sarcoma.